The Tec kinases ITK (interleukin-2-inducible T-cell kinase) and RLK (resting lymphocyte kinase) are critical 27 components of the proximal TCR/CD3 signal transduction machinery, and data in mice suggest that ITK 28 negatively regulates TREG differentiation. However, whether Tec kinases modulate TREG development 29 and/or function in human T cells remains unknown. Using a novel self-delivery siRNA platform (sdRNA), 30
Introduction 42
Interleukin-2-inducible T-cell kinase (ITK) is a member of the TEC kinase family of non-receptor 43 tyrosine kinases and mediates T cell signaling downstream of TCR activation [1] . Signaling through ITK 44 modulates T cell activation, T helper cell differentiation, and thymic selection of developing thymocytes. 45 ITK has been implicated as a critical node in T cell and NK cell mediated inflammation, leading to interest 46 in developing therapeutics to modulate ITK function in autoimmune and inflammatory diseases [2, 3] . 47 ITK is thought to drive Th2-mediated disease such as allergic asthma, and ITK -/mice exhibit significantly 48 improved disease course and reduced bronchoconstriction after antigen re-challenge in ovalbumin 49 sensitized mice [4, 5] . ITK has also been proposed to regulate the balance between inflammatory CD4+ 50 Th17 cells and CD4+ regulatory T cells (TREG) in mice [6] . ITK is an important switch for Th1 and Th2 51 mediated immunity, and murine ITK deficiency results in reduced differentiation and effector cytokine 52 production from Th1, Th2, and Th17 polarized CD4+ T cells while bolstering TREG development [6] [7] [8] [9] . 53 However, since ITK is also involved in thymocyte development [10] , studies in knock-out mice may not 54 distinguish potential developmental defects in the immune system from the effects of ITK inhibition on 55 the mature immune system. Although ITK also serves a scaffolding function for the docking of signaling 56 intermediates (such as Vav1) that coordinate actin polymerization toward the TCR-APC interface [11] , 57 studies in kinase-dead ITK mutant mice have shown that ITK kinase activity was required for driving Th1, 58 Th2, and Th17 differentiation [7, 8] . 59
Resting lymphocyte kinase (RLK) is another member of the TEC family of non-receptor tyrosine 60 kinases closely related to ITK. Less is known about RLK in T cell signaling and differentiation. While both 61 ITK and RLK are activated by Src kinases downstream of the TCR signaling complex, RLK activation is 62 independent of PI3K activation [12] . RLK is constitutively bound to the T cell plasma membrane via an N-63 terminal palmitoylation site, whereas ITK has a pleckstrin homology domain which requires PI3K-64 mediated PIP3 generation for recruitment to the plasma membrane after TCR activation [12] [13] [14] [15] . Txk 65 mRNA (encoding RLK) is also downregulated in T cells following activation [15] . Together this suggests 66 that ITK and RLK play redundant as well as distinct roles in T cell development and activation. In fact, 67
whereas ITK-/-mice exhibit impaired CD4+ and CD8+ T cell development, RLK deficiency alone does not 68 affect T cell development. However, mice that are deficient in both ITK and RLK have a marked defect in 69 T cell activation in response to anti-CD3, but not PMA, stimulation [1] . 70
While ITK is required for IL-17a production in human T cell lines [14] and it also regulates Th17 71 and TREG differentiation in mice [6] , its role in human TREG differentiation is not defined. Here we 72 investigated the roles of ITK in human Foxp3+ TREG differentiation and function using self-delivered siRNA 73 (sdRNA) technology optimized to modulate ITK expression in resting primary human T cells. We found 74 that ITK is a negative regulator of human TREG differentiation under in vitro TREG, Th17, and Th1 polarizing 75 conditions, and that ITK reciprocally regulates TREG and Th17 differentiation from naïve human CD4+ T 76 cells. ITK also regulates the expression of the co-inhibitory molecule PD-1 on in vitro-differentiated 77 human FoxP3+ CD4+ T cells. Of note, pharmacologic inhibition of multiple TEC family kinases (ITK and 78 RLK) blocked the TREG bolstering effect of ITK knockdown, suggesting that RLK may be required for TREG 79 differentiation in the absence of ITK. Our data show for the first time that ITK regulates CD4+ TREG and 80
Th17 differentiation in primary human T cells and highlights the need for more specific pharmacologic 81 targeting of TEC kinases in inflammatory and autoimmune disease. 82
83
Results 85
ITK knockdown in human naïve CD4 T cells promotes Foxp3 + TREG differentiation 86
To assess the effect of ITK on human TREG differentiation, we used a recently developed self-87 delivered siRNA technology (sdRNA; Advirna, Cambridge, MA) which circumvents the low efficiency of 88 conventional gene knockdown methods in resting primary human T cells. ITK sdRNA treatment led to a 89 50%-80% reduction in ITK gene expression relative to a non-targeting sdRNA control (NTC) in human 90 peripheral blood naïve CD4+ T cells ( Figure 1A) . CD4+ T cells were then differentiated under TREG, Th17, 91
Th1, or non-polarizing conditions (Th0). Knockdown of ITK resulted in a 3-8-fold increase in the 92 frequency of FoxP3+ T cells and a 2-5-fold increase in FoxP3 MFI under TREG, Th17 and Th1 polarizing 93 conditions relative to NTC (Figure 1B, C) . These results suggest an inverse relationship between ITK 94 gene expression and FoxP3+ T cell differentiation in human CD4 T cells. 95
ITK knockdown modulates Th17 and Th1 differentiation in human T cells 96
Deletion of ITK in mice leads to increased TREG development under both TREG and Th17 polarizing 97 conditions [6] . While ITK is critical for driving Th2 mediated immune responses and effector cytokine 98 production [9, 16, 17] some studies indicate that ITK is also required for Th1 effector cytokine 99 production in mouse T cells [7, 9, 17] . 100
Th17 cells produce the cytokine IL17A and express the chemokine receptor CCR6. We examined 101 IL17A secretion and surface expression of CCR6 in human Th17 polarized cells upon ITK knock down and 102 observed down-regulation of both markers relative to T cells treated with NTC (Figure 2A, B) . Thus, 103 analogous to mouse T cells [6] , ITK reciprocally regulates the differentiation of TREG and Th17 cells in 104 human primary T cells. 105
Although ITK knockdown led to increased development of FoxP3+ T cells under Th1 polarizing 106 conditions, it also led to increased IFNγ expression ( Figure 2C) . This is in contrast to what has been 107 observed in mice expressing a mutant form of ITK whose kinase activity can be selectively inhibited by 108 small molecule inhibitors, where ITK kinase activity was required for Th1, Th2, and Th17 effector 109 cytokine production [7], or in ITK-/-mice, which exhibit normal Th1 differentiation [5, 6] . 110
ITK knockdown increases the proportion of human TREG expressing the co-inhibitory receptor PD-1.
While FoxP3 is a requisite marker of bona-fide regulatory T cells, in humans it may not be sufficient to 112 define functional TREG cells. Thus, we further assessed surface expression of the co-inhibitory receptor 113 PD-1 upon ITK knock down in TREG polarized cells. Consistent with a negative role of ITK in functional 114 human TREG differentiation, ITK knockdown led to a significant increase in the proportion of FoxP3+ cells 115 expressing the co-inhibitory molecule PD-1, suggesting that the increase in Foxp3+ T cells correlates with 116 functional suppressive capacity (Figure 3) . 117
ITK knockdown increases the proportion of functionally suppressive human TREG 118
Given that ITK knockdown bolsters TREG abundance and increases FoxP3 and PD-1 expression, we 119 next examined the functionality of TREGS differentiated in vitro in the presence of ITK sdRNA. In vitro 120 differentiated TREGS were co-cultured with CFSE-labeled CD4+ responder cells and anti-CD3 anti-CD28 121 activation beads, and responder T cell proliferation was measured based on CFSE dilution (Figure 4A) . 122 TREG differentiated in vitro in the presence of both ITK and NTC sdRNA were suppressive against effector 123 cell proliferation in a TREG-dose dependent manner (Figure 4B) . While TREGS differentiated in the 124 presence of ITK sdRNA appeared to exhibit enhanced suppressive capacity in this assay, ITK knockdown 125 leads to increased TREG abundance (Figure 1) . Thus, despite observing increased PD-1 expression, our 126 current data do not allow us to determine whether ITK knockdown enhances TREG suppression on a per-127 cell basis. Nonetheless, we can conclude that TREGs differentiated in vitro from naïve human CD4+ T cells 128 are bona fide regulatory T cells and that ITK knockdown can promote increased differentiation (Figure 1 Studies in ITK deficient mice have fostered significant interest in targeting this kinase in 133 autoimmune and inflammatory diseases [6, 7, 9, 18] . The novel covalent inhibitor PRN694 targets mainly 134 ITK and RLK, and it blocks T cell activation, proliferation, and T helper cell differentiation [2, 3] . 135 Furthermore, this compound ameliorated colitis progression in the T cell transfer colitis model by 136
blunting both Th1 and Th17 responses [2] . However, in contrast to ITK-deficient mice, PRN694-treated 137 mice exhibit reduced TREG numbers, suggesting that RLK may play a distinct role in TREG differentiation [2, 138 6] . In agreement with the findings in mice, PRN694 inhibited human T cell activation and TREG 139 differentiation in a dose-dependent manner, thus abrogating the increase in TREGS observed upon ITK 140 knockdown (Figure 5) .
Since RLK expression is suppressed after T cell activation [15] , this Tec kinase is likely to be 142 involved in early T cell activation events which are required to drive both T helper and TREG 143 differentiation. We attempted to isolate the effect of RLK on TREG differentiation using sdRNA 144 knockdown, but none of the eleven sdRNA constructs we tested alone or in combination reduced Txk 145 gene expression (data not shown). Thus, while it is possible that RLK and ITK play distinct roles in TREG 146 and T helper differentiation, at this point we cannot determine whether these Tec kinases play 147 redundant or reciprocal roles in this regard. 148 149 Discussion 151
The TEC family of tyrosine kinases, including ITK and RLK, are critical for TCR-mediated T cell 152 activation and T helper cell differentiation, and they are likely to play distinct roles in these processes. 153
We show here for the first time that ITK is a negative regulator of human Foxp3+ TREG and Th1 154 development, with a reciprocal effect on Th17 differentiation. Our findings extend recent observations 155 in ITK deficient mice, which display enhanced TREG development in vivo and in vitro and diminished T 156 effector development and function [6, 7, 9] . 157
In addition, we observed a marked increase in IFNγ production by Th1 polarized cells after ITK 158 knockdown. ITK has a well-established role in Th2 mediated inflammation, but reports are conflicting on 159 its role in Th1 effector function [5, 7, 9, [19] [20] [21] . While some data indicate that ITK positively regulates 160 Th1 development and effector function in mouse T cells [7, 9, 20, 21] , our data suggest that ITK is 161 dispensable for Th1 effector function in primary human T cells, and that targeting ITK alone is therefore 162 unlikely to be broadly immunosuppressive. 163
While RLK and ITK might fulfill some redundant roles [4], pharmacologic inhibition of both ITK 164 and RLK in human naïve T cells globally blocked T cell activation and TREG differentiation. This is 165 consistent with observations in ITK/RLK double knockout mice, which showed markedly impaired TCR-166 mediated T cell proliferation [1] . Nonetheless, while ITK knockdown markedly enhanced human TREG 167 differentiation from naïve T cells, ITK knockdown followed by pharmacologic inhibition of ITK and RLK 168 abrogated this effect, suggesting that, in contrast to ITK, RLK is not involved in TREG suppression but is 169 actually required for TREG differentiation in the absence of ITK. ITK and RLK are both activated 170 downstream of TCR ligation however, in contrast to ITK, RLK activation is independent of the PI3K-AKT 171 axis [12] which is integral for the repression of FoxP3 protein and gene transcription [22, 23] . RLK also 172 independently phosphorylates the adapter molecule SLP-76 leading to PLCγ activation [24] , which 173 explains its compensatory role in T cell activation and differentiation in the absence of ITK. Therefore, 174 our data support a model whereby selective inhibition of ITK de-represses FoxP3 via inhibition of PI3K-175 AKT signaling while sparing RLK to promote PLCγ-mediated T cell activation and differentiation. 176
While we have shown that ITK knockdown enhances the in vitro differentiation of human TREG 177 with functional suppressive capacity in vitro, we cannot conclude whether ITK knockdown affects TREG 178 suppression on a per cell basis. In fact, even though initial ITK knockdown promotes TREG differentiation, 179 sdRNA content is expected to decrease due to initial T cell proliferation and/or degradation, and 180 therefore our data cannot determine whether ITK is truly dispensable for TREG suppressive function. The 181 latter is a potentially important question, because a previous report showed that TREG from ITK-deficient 182 mice did not protect in a colitis model [8] , although another paper showed that ex vivo-induced ITK-/-183 TREG efficiently abrogated inflammation in a similar model [6] . 184
The reciprocal effects of ITK on effector T cell and TREG differentiation makes this a potentially 185 attractive target in autoimmune and inflammatory diseases. However, the lack of small molecule 186 
Materials and Methods 194
Cell culture: Naïve CD4+ CD45RA+ CD25-peripheral blood T cells were purchased from AllCells 195 (Alameda, CA). T cells were cultured in RPMI 1640 media with pen/strep and 10% HI-FCS on wells coated 196 with 1ug/ml of anti-CD3 (OKT3, eBioscience). Th cell polarization conditions were as follows. TREGS: 197 300U/ml of IL-2, 5ng/ml of rhTGFβ, 1ug/ml of anti-CD28. For Th17: IL-23 10ng/ml, TGFβ 0.5ng/ml, 10ng/ml, IL-2 20U/ml, anti-INFγ 10ug/ml, anti-IL4 10ug/ml and anti-CD28 1ug/ml. For Th1: anti-IL4 199 10ug/ml, anti-CD28 1ug/ml, rh IL-2 20U/ml and rh IL-12 10ng/ml. concentrations per manufacturer specifications for 24hrs, serum was added to 10% for an additional 206 24hrs then cells were transferred to media conditioned for TREG, Th17, Th1 or Th0 differentiation. Gene 207 expression analysis was performed 72hr post-sdRNA addition to assess extent of ITK knockdown. Cells 208 were analyzed after 4 days in TREG or TEFF polarizing conditions by flow cytometry for FoxP3+ regulatory T 209 cells, CCR6 for Th17 and IFNγ for Th1. Several ITK-targeting sdRNA constructs were assessed in 210 comparison to a non-targeting control (NTC) for ITK knock-down and FoxP3 upregulation and one 211 construct (ITK49) was selected based on optimal knockdown efficiency and FoxP3+ TREG induction (data 212 not shown). 213
In vitro suppression assay: TREGS were differentiated as indicated above with ITK or NTC sdRNA for 4 days 214 then collected and labeled with CellTrace Violet (Life Technologies). CD4+ peripheral blood responder 215 cells (AllCells; Alameda, CA) were labeled with CFSE. TREGS and responder cells were cultured with anti-216 CD3/CD28 activation beads (1:10 bead:responder cell ratio; Miltenyi) at TREG:responder cell ratios of 1:8 217 to 1:1 and were incubated together for 72 hours. After 72 hours, the cells were fixed and flow cytometry 218 was run on the BD LSR-II to determine proliferation. Proliferation profile and division index analysis with 219 Statistics: Results are expressed as the mean +/-SEM. Statistical differences between 2 groups were 236 calculated by unpaired student's t test and among more than two groups by ANOVA. Graphs were 237 generated with Prism-GraphPad software. 238 Human naïve T cells were treated with ITK or NTC sdRNAs and differentiated under TREG polarizing 342 conditions (iTREG). In vitro suppression assays were set up with iTREG labeled with CellTrace Violet (CVT)  343 and CD4 + CD25responder T cells labeled with CFSE in the presence of anti-CD3/CD28 activation beads. 344 FACS analysis was performed after 4 days (A, 1:1 cell ratio shown) and the FlowJo proliferation platform 345 was used to calculate the division index (DI; B) 
